In order to create a cell-line model of resistance to ROS1 inhibition, we chronically treated the SLC34A2-ROS1 expressing NSCLC cell line HCC78 with increasing concentrations of the ROS1 inhibitor TAE684. The gene discussed is ROS1; the disease is non-small cell lung carcinoma.